ICAM1 and cancer: Growing evidence suggests that ICAM-1 expression is upregulated in various immunological disorders including tissues undergoing autoimmune injury and inflammation as well as in malignant tumors.1,43 In this report, MTX-cLABL and MTX-cLBEL maintained their ICAM-1 binding properties.